CDXI vs GILD: Which Stock is Better?
Side-by-side comparison of Cardax Inc and Gilead Sciences Inc in 2026
CDXI
Cardax Inc
$0.00
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | CDXI | GILD | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.3% | 0.0% | GILD |
| Gross Margin | 65.7% | 78.8% | GILD |
Analyze CDXI
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXI or GILD a better investment?
Comparing CDXI and GILD: Cardax Inc has a market cap of $0.00M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXI and GILD?
CDXI (Cardax Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXI or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXI or GILD?
GILD has higher revenue growth at 0.0% vs -0.3% for CDXI.
Which company is more profitable: CDXI or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 65.7% for CDXI.
Which is the larger company: CDXI or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $0.00M for CDXI.
Should I buy CDXI or GILD in 2026?
Both CDXI and GILD have investment merit. CDXI trades at $0.00 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXI and GILD stock?
Key differences: Market Cap ($0.00M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (65.7% vs 78.8%).